'''Formebolone''' ([[International Nonproprietary Name|INN]], [[British Approved Name|BAN]]) (brand names '''Esiclene''', '''Hubernol''', '''Metanor'''), also known (confusingly) as '''formyldienolone''', as well as '''2-formyl-11α-hydroxy-17α-methyl-δ<sup>1</sup>-testosterone''', is an [[oral administration|orally active]] [[anabolic-androgenic steroid]] (AAS) described as an [[anticatabolic]] and [[anabolic drug|anabolic]] [[drug]] that is or has been marketed in [[Spain]] and [[Italy]].<ref name="IndexNominum2000">{{cite book|title=Index Nominum 2000: International Drug Directory|url=https://books.google.com/books?id=5GpcTQD_L2oC&pg=PA471|date=January 2000|publisher=Taylor & Francis|isbn=978-3-88763-075-1|pages=471–}}</ref><ref name="Elks2014">{{cite book|author=J. Elks|title=The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies|url=https://books.google.com/books?id=0vXTBwAAQBAJ&pg=PA577%7Cdate%3D14+November+2014%7Cpublisher%3DSpringer%7Cisbn%3D978-1-4757-2085-3%7Cpages%3D577%E2%80%93%7D%7D%3C%2Fref%3E|date=14 November 2014|publisher=Springer|isbn=978-1-4757-2085-3|pages=577–}}</ref><ref name="MortonHall1999">{{cite book|author1=I.K. Morton|author2=Judith M. Hall|title=Concise Dictionary of Pharmacological Agents: Properties and Synonyms|url=https://books.google.com/books?id=mqaOMOtk61IC&pg=PA125|date=31 October 1999|publisher=Springer Science & Business Media|isbn=978-0-7514-0499-9|pages=125–}}</ref> As an AAS, it shows some anabolic activity, though it is inferior to [[testosterone]] in terms of [[potency (pharmacology)|potency]], but is said to have virtually no [[androgen]]ic activity.<ref name="pmid799985">{{cite journal |vauthors=Gelli D, Vignati E |title=Metabolic studies with formebolone (2-formyl-17 (alpha)-methyl-androsta-1,4-diene-11 (alpha), 17 (beta)-diol-3-one) in humans |journal=J. Int. Med. Res. |volume=4 |issue=2 |pages=96–105 |year=1976 |pmid=799985 |doi= 10.1177/030006057600400203|url=}}</ref> Formebolone counteracts the [[catabolic]] effects (control of [[nitrogen balance]]) of potent [[glucocorticoid]]s like [[dexamethasone phosphate]].<ref name="pmid799985" /><ref name="pmid1036699">{{cite journal |vauthors=Cerutti S, Forlani A, Galimberti E |title=Anticatabolic action of formebolone in the castrated rat treated with dexamethasone |journal=Arzneimittelforschung |volume=26 |issue=9 |pages=1673–7 |year=1976 |pmid=1036699 |doi= |url=}}</ref> A close [[structural analog|analogue]], [[roxibolone]] (and its long-acting [[ester]] variant [[decylroxibolone]]), shows similar antiglucocorticoid activity to formebolone but, in contrast, is devoid of activity as an AAS.<ref name="pmid6523544">{{cite journal |vauthors=Felippone F, Resnati G, Scolastico C, Tronconi G |title=Synthesis of 2-carboxy-11 beta, 17 beta-dihydroxy-17-methyl-1, 4-androstadien-3-one and related compounds |journal=Steroids |volume=43 |issue=3 |pages=271–82 |year=1984 |pmid=6523544 |doi= 10.1016/0039-128x(84)90045-x|url=}}</ref>
